ParkinsonFranceV1, Hal, Curation, bibRecord, 000084

Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies

Identifieur interne : 000084 ( Hal/Curation ); précédent : 000083; suivant : 000085

Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies

Auteurs : Erwan Bezard [France] ; Zhenyu Yue [États-Unis] ; Deniz Kirik [Suède] ; Maria Grazia Spillantini [Royaume-Uni]

Source :

Movement Disorders [ 0885-3185 ] ; 2013-01.

RBID : Hal:hal-01290064

Abstract

Over the last two decades, significant strides has been made toward acquiring a better knowledge of both the etiology and pathogenesis of Parkinson's disease (PD). Experimental models are of paramount importance to obtain greater insights into the pathogenesis of the disease. Thus far, neurotoxin-based animal models have been the most popular tools employed to produce selective neuronal death in both in vitro and in vivo systems. These models have been commonly referred to as the pathogenic models. The current trend in modeling PD revolves around what can be called the disease gene-based models or etiologic models. The value of utilizing multiple models with a different mechanism of insult rests on the premise that dopamine-producing neurons die by stereotyped cascades that can be activated by a range of insults, from neurotoxins to downregulation and overexpression of disease-related genes. In this position article, we present the relevance of both pathogenic and etiologic models as well as the concept of clinically relevant designs that, we argue, should be utilized in the preclinical development phase of new neuroprotective therapies before embarking into clinical trials.

Url:

https://hal.archives-ouvertes.fr/hal-01290064

DOI: 10.1002/mds.25108

Links toward previous steps (curation, corpus...)

to stream Hal, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000089

Links to Exploration step

Hal:hal-01290064

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies</title>
<author><name sortKey="Bezard, Erwan" sort="Bezard, Erwan" uniqKey="Bezard E" first="Erwan" last="Bezard">Erwan Bezard</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-244085" status="VALID">  <orgName>Institut des Maladies Neurodégénératives [Bordeaux]</orgName>
  <orgName type="acronym">IMN</orgName>
  <desc>    <address>      <addrLine>Bât. 3b 1er étage 146 Rue Léo Saignat 33076 Bordeaux </addrLine>
      <country key="FR"></country>
    </address>
    <ref type="url">http://imn-bordeaux.org/</ref>
  </desc>
  <listRelation>    <relation active="#struct-259761" type="direct"></relation>
    <relation name="UMR5293" active="#struct-441569" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-259761" type="direct"><org type="institution" xml:id="struct-259761" status="VALID">  <orgName>Université de Bordeaux</orgName>
  <orgName type="acronym">UB</orgName>
  <desc>    <address>      <addrLine>35, place Pey Berland - 33076 Bordeaux</addrLine>
      <country key="FR"></country>
    </address>
    <ref type="url">http://www.u-bordeaux.fr/</ref>
  </desc>
</org>
</tutelle>
<tutelle name="UMR5293" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID">  <idno type="IdRef">02636817X</idno>
  <idno type="ISNI">0000000122597504</idno>
  <orgName>Centre National de la Recherche Scientifique</orgName>
  <orgName type="acronym">CNRS</orgName>
  <date type="start">1939-10-19</date>
  <desc>    <address>      <country key="FR"></country>
    </address>
    <ref type="url">http://www.cnrs.fr/</ref>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
<placeName><settlement type="city">Bordeaux</settlement>
<region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
</placeName>
<orgName type="university">Université de Bordeaux</orgName>
</affiliation>
</author>
<author><name sortKey="Yue, Zhenyu" sort="Yue, Zhenyu" uniqKey="Yue Z" first="Zhenyu" last="Yue">Zhenyu Yue</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-262413" status="INCOMING">  <orgName>Departments of Neurology and Neuroscience</orgName>
  <desc>    <address>      <addrLine>Friedman Brain Institute, New York</addrLine>
      <country key="US"></country>
    </address>
  </desc>
  <listRelation>    <relation active="#struct-362271" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-362271" type="direct"><org type="institution" xml:id="struct-362271" status="INCOMING">  <orgName>Friedman Brain Institute, New York</orgName>
  <desc>    <address>      <country key="FR"></country>
    </address>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Kirik, Deniz" sort="Kirik, Deniz" uniqKey="Kirik D" first="Deniz" last="Kirik">Deniz Kirik</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-262686" status="INCOMING">  <orgName>Brain Repair And Imaging in Neural Systems Unit</orgName>
  <desc>    <address>      <addrLine>Department of Experimental Medical Science, Lund University, Lund</addrLine>
      <country key="SE"></country>
    </address>
  </desc>
  <listRelation>    <relation active="#struct-365457" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-365457" type="direct"><org type="institution" xml:id="struct-365457" status="VALID">  <orgName>Lund University</orgName>
  <desc>    <address>      <country key="SE"></country>
    </address>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Spillantini, Maria Grazia" sort="Spillantini, Maria Grazia" uniqKey="Spillantini M" first="Maria Grazia" last="Spillantini">Maria Grazia Spillantini</name>
<affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-237843" status="VALID">  <orgName>University of Cambridge</orgName>
  <orgName type="acronym">CAM</orgName>
  <desc>    <address>      <addrLine>The Old Schools, Trinity Lane, Cambridge CB2 1TN</addrLine>
      <country key="GB"></country>
    </address>
    <ref type="url">http://www.cam.ac.uk/</ref>
  </desc>
</hal:affiliation>
<country>Royaume-Uni</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:hal-01290064</idno>
<idno type="halId">hal-01290064</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-01290064</idno>
<idno type="url">https://hal.archives-ouvertes.fr/hal-01290064</idno>
<idno type="doi">10.1002/mds.25108</idno>
<date when="2013-01">2013-01</date>
<idno type="wicri:Area/Hal/Corpus">000089</idno>
<idno type="wicri:Area/Hal/Curation">000089</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies</title>
<author><name sortKey="Bezard, Erwan" sort="Bezard, Erwan" uniqKey="Bezard E" first="Erwan" last="Bezard">Erwan Bezard</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-244085" status="VALID">  <orgName>Institut des Maladies Neurodégénératives [Bordeaux]</orgName>
  <orgName type="acronym">IMN</orgName>
  <desc>    <address>      <addrLine>Bât. 3b 1er étage 146 Rue Léo Saignat 33076 Bordeaux </addrLine>
      <country key="FR"></country>
    </address>
    <ref type="url">http://imn-bordeaux.org/</ref>
  </desc>
  <listRelation>    <relation active="#struct-259761" type="direct"></relation>
    <relation name="UMR5293" active="#struct-441569" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-259761" type="direct"><org type="institution" xml:id="struct-259761" status="VALID">  <orgName>Université de Bordeaux</orgName>
  <orgName type="acronym">UB</orgName>
  <desc>    <address>      <addrLine>35, place Pey Berland - 33076 Bordeaux</addrLine>
      <country key="FR"></country>
    </address>
    <ref type="url">http://www.u-bordeaux.fr/</ref>
  </desc>
</org>
</tutelle>
<tutelle name="UMR5293" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID">  <idno type="IdRef">02636817X</idno>
  <idno type="ISNI">0000000122597504</idno>
  <orgName>Centre National de la Recherche Scientifique</orgName>
  <orgName type="acronym">CNRS</orgName>
  <date type="start">1939-10-19</date>
  <desc>    <address>      <country key="FR"></country>
    </address>
    <ref type="url">http://www.cnrs.fr/</ref>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
<placeName><settlement type="city">Bordeaux</settlement>
<region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
</placeName>
<orgName type="university">Université de Bordeaux</orgName>
</affiliation>
</author>
<author><name sortKey="Yue, Zhenyu" sort="Yue, Zhenyu" uniqKey="Yue Z" first="Zhenyu" last="Yue">Zhenyu Yue</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-262413" status="INCOMING">  <orgName>Departments of Neurology and Neuroscience</orgName>
  <desc>    <address>      <addrLine>Friedman Brain Institute, New York</addrLine>
      <country key="US"></country>
    </address>
  </desc>
  <listRelation>    <relation active="#struct-362271" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-362271" type="direct"><org type="institution" xml:id="struct-362271" status="INCOMING">  <orgName>Friedman Brain Institute, New York</orgName>
  <desc>    <address>      <country key="FR"></country>
    </address>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Kirik, Deniz" sort="Kirik, Deniz" uniqKey="Kirik D" first="Deniz" last="Kirik">Deniz Kirik</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-262686" status="INCOMING">  <orgName>Brain Repair And Imaging in Neural Systems Unit</orgName>
  <desc>    <address>      <addrLine>Department of Experimental Medical Science, Lund University, Lund</addrLine>
      <country key="SE"></country>
    </address>
  </desc>
  <listRelation>    <relation active="#struct-365457" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-365457" type="direct"><org type="institution" xml:id="struct-365457" status="VALID">  <orgName>Lund University</orgName>
  <desc>    <address>      <country key="SE"></country>
    </address>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Spillantini, Maria Grazia" sort="Spillantini, Maria Grazia" uniqKey="Spillantini M" first="Maria Grazia" last="Spillantini">Maria Grazia Spillantini</name>
<affiliation wicri:level="1"><hal:affiliation type="institution" xml:id="struct-237843" status="VALID">  <orgName>University of Cambridge</orgName>
  <orgName type="acronym">CAM</orgName>
  <desc>    <address>      <addrLine>The Old Schools, Trinity Lane, Cambridge CB2 1TN</addrLine>
      <country key="GB"></country>
    </address>
    <ref type="url">http://www.cam.ac.uk/</ref>
  </desc>
</hal:affiliation>
<country>Royaume-Uni</country>
</affiliation>
</author>
</analytic>
<idno type="DOI">10.1002/mds.25108</idno>
<series><title level="j">Movement Disorders</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date type="datePub">2013-01</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Over the last two decades, significant strides has been made toward acquiring a better knowledge of both the etiology and pathogenesis of Parkinson's disease (PD). Experimental models are of paramount importance to obtain greater insights into the pathogenesis of the disease. Thus far, neurotoxin-based animal models have been the most popular tools employed to produce selective neuronal death in both in vitro and in vivo systems. These models have been commonly referred to as the pathogenic models. The current trend in modeling PD revolves around what can be called the disease gene-based models or etiologic models. The value of utilizing multiple models with a different mechanism of insult rests on the premise that dopamine-producing neurons die by stereotyped cascades that can be activated by a range of insults, from neurotoxins to downregulation and overexpression of disease-related genes. In this position article, we present the relevance of both pathogenic and etiologic models as well as the concept of clinically relevant designs that, we argue, should be utilized in the preclinical development phase of new neuroprotective therapies before embarking into clinical trials.</div>
</front>
</TEI>
<hal api="V3">          <titleStmt>            <title xml:lang="en">Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies</title>
            <author role="aut">              <persName>                <forename type="first">Erwan</forename>
                <surname>Bezard</surname>
              </persName>
              <idno type="halauthorid">537314</idno>
              <affiliation ref="#struct-244085"></affiliation>
            </author>
            <author role="aut">              <persName>                <forename type="first">Zhenyu</forename>
                <surname>Yue</surname>
              </persName>
              <idno type="halauthorid">766420</idno>
              <affiliation ref="#struct-262413"></affiliation>
            </author>
            <author role="aut">              <persName>                <forename type="first">Deniz</forename>
                <surname>Kirik</surname>
              </persName>
              <idno type="halauthorid">839501</idno>
              <affiliation ref="#struct-262686"></affiliation>
            </author>
            <author role="aut">              <persName>                <forename type="first">Maria Grazia</forename>
                <surname>Spillantini</surname>
              </persName>
              <idno type="halauthorid">1061270</idno>
              <affiliation ref="#struct-237843"></affiliation>
            </author>
            <editor role="depositor">              <persName>                <forename>Chantal</forename>
                <surname>GUERIN</surname>
              </persName>
              <email type="md5">eb4bde61f74652335183b0bd05630b2c</email>
              <email type="domain">u-bordeaux.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>            <edition n="v1" type="current">              <date type="whenSubmitted">2016-03-17 15:23:20</date>
              <date type="whenModified">2016-03-18 01:00:30</date>
              <date type="whenReleased">2016-03-17 15:23:20</date>
              <date type="whenProduced">2013-01</date>
            </edition>
            <respStmt>              <resp>contributor</resp>
              <name key="321070">                <persName>                  <forename>Chantal</forename>
                  <surname>GUERIN</surname>
                </persName>
                <email type="md5">eb4bde61f74652335183b0bd05630b2c</email>
                <email type="domain">u-bordeaux.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>            <distributor>CCSD</distributor>
            <idno type="halId">hal-01290064</idno>
            <idno type="halUri">https://hal.archives-ouvertes.fr/hal-01290064</idno>
            <idno type="halBibtex">bezard:hal-01290064</idno>
            <idno type="halRefHtml">Movement Disorders, Wiley, 2013, 28 (1), <10.1002/mds.25108></idno>
            <idno type="halRef">Movement Disorders, Wiley, 2013, 28 (1), <10.1002/mds.25108></idno>
          </publicationStmt>
          <seriesStmt>            <idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
          </seriesStmt>
          <notesStmt>            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>            <biblStruct>              <analytic>                <title xml:lang="en">Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies</title>
                <author role="aut">                  <persName>                    <forename type="first">Erwan</forename>
                    <surname>Bezard</surname>
                  </persName>
                  <idno type="halauthorid">537314</idno>
                  <affiliation ref="#struct-244085"></affiliation>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Zhenyu</forename>
                    <surname>Yue</surname>
                  </persName>
                  <idno type="halauthorid">766420</idno>
                  <affiliation ref="#struct-262413"></affiliation>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Deniz</forename>
                    <surname>Kirik</surname>
                  </persName>
                  <idno type="halauthorid">839501</idno>
                  <affiliation ref="#struct-262686"></affiliation>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Maria Grazia</forename>
                    <surname>Spillantini</surname>
                  </persName>
                  <idno type="halauthorid">1061270</idno>
                  <affiliation ref="#struct-237843"></affiliation>
                </author>
              </analytic>
              <monogr>                <idno type="halJournalId" status="VALID">17211</idno>
                <idno type="issn">0885-3185</idno>
                <idno type="eissn">1531-8257</idno>
                <title level="j">Movement Disorders</title>
                <imprint>                  <publisher>Wiley</publisher>
                  <biblScope unit="volume">28</biblScope>
                  <biblScope unit="issue">1</biblScope>
                  <date type="datePub">2013-01</date>
                </imprint>
              </monogr>
              <idno type="doi">10.1002/mds.25108</idno>
              <idno type="pubmed">22753348</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>            <langUsage>              <language ident="en">English</language>
            </langUsage>
            <textClass>              <classCode scheme="halDomain" n="sdv">Life Sciences [q-bio]</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">Over the last two decades, significant strides has been made toward acquiring a better knowledge of both the etiology and pathogenesis of Parkinson's disease (PD). Experimental models are of paramount importance to obtain greater insights into the pathogenesis of the disease. Thus far, neurotoxin-based animal models have been the most popular tools employed to produce selective neuronal death in both in vitro and in vivo systems. These models have been commonly referred to as the pathogenic models. The current trend in modeling PD revolves around what can be called the disease gene-based models or etiologic models. The value of utilizing multiple models with a different mechanism of insult rests on the premise that dopamine-producing neurons die by stereotyped cascades that can be activated by a range of insults, from neurotoxins to downregulation and overexpression of disease-related genes. In this position article, we present the relevance of both pathogenic and etiologic models as well as the concept of clinically relevant designs that, we argue, should be utilized in the preclinical development phase of new neuroprotective therapies before embarking into clinical trials.</abstract>
          </profileDesc>
        </hal>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Hal/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000084 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Hal/Curation/biblio.hfd -nk 000084 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Hal
   |étape=   Curation
   |type=    RBID
   |clé=     Hal:hal-01290064
   |texte=   Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies
}}

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies

Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies

Source :

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri